Not finding it? Sign in to also search OpenAlex live.
-
Population Pharmacokinetic and Pharmacogenetic Analysis of Mitotane in Patients with Adrenocortical Carcinoma: Towards Individualized Dosing2020 Clinical Pharmacokinetics article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Anyue Yin, Madeleine H. T. Ettaieb, Jesse Joachim Swen, Liselotte van Deun, Thomas M. A. Kerkhofs, R.J.H.M. van der Straaten, +11 more
13citations -
Survival of Patients With Cancer With DPYD Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy—A Matched-Pair Analysis2023 Journal of Clinical Oncology article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Jonathan Emanuel Knikman, Tycho A. Wilting, Marta López‐Yurda, Linda M. Henricks, Carin A.T.C. Lunenburg, Femke M. de Man, +18 more
56citations -
Individualized Dosing Patterns in the Treatment of Older Patients with Gastrointestinal Stromal Tumors: Results of a Registry-Based Observational National Cohort Study Including 871 Patients
Roos F. Bleckman, K. Esther Broekman, Evelyne Roets, Mohammed Mohammadi, Ingrid M.E. Desar, Hans A. J. Gelderblom, +4 more
1citations -
Individualized Dosing of Fluoropyrimidine‐Based Chemotherapy to Prevent Severe Fluoropyrimidine‐Related Toxicity: What Are the Options?2020 Clinical Pharmacology & Therapeutics article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Jonathan Emanuel Knikman, Hans A. J. Gelderblom, Jos H. Beijnen, Annemieke Cats, Henk‐Jan Guchelaar, Linda M. Henricks
78citations -
A Population Pharmacokinetic Model and Dosing Algorithm to Guide the Tacrolimus Starting and Follow-Up Dose in Living and Deceased Donor Kidney Transplant Recipients2025 Clinical Pharmacokinetics article Medicine Renal Transplantation Outcomes and Treatments Open access
Marith I. Francke, Sebastiaan D. T. Sassen, Núria Lloberas, Helena Colom, Laure Elens, Serge Moudio, +5 more
11citations -
CYP2B6 Functional Variability in Drug Metabolism and Exposure Across Populations—Implication for Drug Safety, Dosing, and Individualized Therapy2021 Frontiers in Genetics article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Immaculate Mbongo Langmia, Katja Susanne Just, Sabrina Yamoune, Jürgen Brockmöller, Collen Mutowembwa Masimirembwa, Julia Stingl
95citations -
A Systematic Evaluation of the Dosing Regimens for Approved Targeted Therapies and Immune Checkpoint Inhibitors in Metastatic Renal Cell Carcinoma From a Project OPTIMUS Perspective2025 The Journal of Clinical Pharmacology review Medicine Renal cell carcinoma treatment Open access
Zhiyuan Tan, Swantje Völler, Aymara Sancho‐Araiz, Catherijne A. J. Knibbe, Dirk Jan A. R. Moes
3citations -
Prospective Open-Label Phase II Trial of Individualized Anti-Thymocyte Globulin for Improved T-Cell Reconstitution after Pediatric Allogeneic Hematopoietic Cell Transplantation: The Parachute-Study2020 Transplantation and Cellular Therapy article Medicine Hematopoietic Stem Cell Transplantation Open access
Rick Admiraal, Stefan Nierkens, Robbert G. M. Bredius, Marc Bierings, Ineke van Vliet, Marta Lopez Yurda, +4 more
10citations -
Feasibility and clinical outcomes of imatinib personalized dosing in gastrointestinal stromal tumor patients.2025 Journal of Clinical Oncology conference-abstract Medicine Gastrointestinal Tumor Research and Treatment
Maud B. A. van der Kleij, Eline L. Giraud, Niels A.D. Guchelaar, Kim Westerdijk, Marinda Meertens, Roos F. Bleckman, +12 more
1citations -
The pharmacokinetics of antibiotics in patients with obesity: a systematic review and consensus guidelines for dose adjustments2025 The Lancet Infectious Diseases review Medicine Antibiotics Pharmacokinetics and Efficacy Open access
Anne‐Grete Märtson, Katie E. Barber, Ryan L. Crass, Maya Hites, Charlotte Kloft, Joseph L. Kuti, +5 more
24citations -
707P Personalised dosing of oral targeted therapies in oncology: The era of therapeutic drug monitoring2023 Annals of Oncology article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Maud B. A. van der Kleij, Niels A.D. Guchelaar, Marinda Meertens, Eline L. Giraud, Roos F. Bleckman, Alexander L.T. Imholz, +14 more
1citations -
POS0609 A TOCILIZUMAB DOSING STRATEGY IN RHEUMATOID ARTHRITIS PATIENTS WITH STABLE DISEASE AIMING TO PREVENT OVERTREATMENT AND UNNECESSARY COSTS2021 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies
K. van Soest, Niels W. Boone, S. Ramiro, M. Starmans, Nieko C. Punt, Robert Landewé
0citations -
Defining the unbound target exposure of teicoplanin, Part 2: Dose individualization through population pharmacokinetic modelling2026 Clinical Microbiology and Infection article Medicine Antibiotics Pharmacokinetics and Efficacy Open access
Jaap W.A. Mouton, Nynke G L Jager, Eveline Wallenburg, Jeroen A. Schouten, Walter J. F. M. van der Velden, Lenneke F. J. van Groningen, +6 more
2citations -
Moving the needle for oncology dose optimization: A call for action2024 Clinical and Translational Science article Mathematics Statistical Methods in Clinical Trials Open access
Karthik Venkatakrishnan, Priya Jayachandran, Shirley K. Seo, Piet H. van der Graaf, John A. Wagner, Neeraj Gupta
2citations -
Unraveling the complexity of therapeutic drug monitoring for monoclonal antibody therapies to individualize dose in oncology2021 Pharmacology Research & Perspectives article Medicine Monoclonal and Polyclonal Antibodies Research Open access
Étienne Chatelut, Jeroen J. M. A. Hendrikx, Jennifer Martin, Joseph Ciccolini, Dirk Jan A. R. Moes
40citations -
Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels: the Alpe2U study2025 European Journal of Cancer article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Jonathan Emanuel Knikman, Mirjam de With, Niels Heersche, Marta López‐Yurda, Arnold Baars, Geert‐Jan Creemers, +22 more
17citations -
70P Fluoropyrimidine (FP) dose individualization based on pretreatment uracil levels: Safety and pharmacokinetic (PK) analysis from the Alpe2U study2022 Annals of Oncology article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Mirjam de With, Jonathan Emanuel Knikman, A. Baars, G-J.M. Creemers, H.J. Droogendijk, Edward Fiets, +14 more
1citations -
Response to Letter Re: Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels2025 European Journal of Cancer article Medicine Colorectal Cancer Treatments and Studies Open access
Niels Heersche, Ron H.J. Mathijssen, Annemieke Cats, Henk‐Jan Guchelaar, Jonathan Emanuel Knikman
0citations -
Development of a dosing algorithm integrating pharmacogenetic markers and inflammation for individualization of initial voriconazole maintenance doses2026 Antimicrobial Agents and Chemotherapy article Medicine Antifungal resistance and susceptibility Open access
Elodie Gautier‐Veyret, O. Giannoni, Marc Manceau, Capucine Arrivé, Sylvia D. Klomp, Matthieu Roustit, +15 more
0citations